55 results
Page 2 of 3
6-K
EX-99.1
vwhd0a49 bwxsn98ilb
29 Dec 21
SciSparc Provides Updates Upon Conclusion of 2021
5:12pm
6-K
EX-99.3
myzls60zrp6fvnzg
2 Mar 21
Report of Foreign Private Issuer
4:05pm
6-K
EX-99.2
vki jd9mro7hd2l
2 Mar 21
Report of Foreign Private Issuer
4:05pm
6-K
EX-99.1
f52 rtowa
24 Feb 21
SciSparc Corporate Presentation February 2021
9:27am
6-K
EX-99.1
rudqmyd
2 Dec 20
Therapix Biosciences to Collaborate with The University of Calgary to Further Examine its Proprietary Drug Candidate THX-160 for Pain
9:25am
6-K
EX-99.1
fuzd becbbmmw96
24 Nov 20
Therapix Biosciences Announces Pricing of $4.2 Million Offering
1:13pm
6-K
EX-1.1
luvbs0gmn
24 Nov 20
Therapix Biosciences Announces Pricing of $4.2 Million Offering
1:13pm
FWP
au5 yf3w489
5 Nov 20
Free writing prospectus
5:11pm
F-1/A
EX-1.1
59y498ezx8yayggqzi4
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
EX-4.6
8en1 i3d2
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
FWP
l2oisvj520
21 Oct 20
Free writing prospectus
7:26am
F-1/A
EX-1.1
0io00xho
9 Oct 20
Registration statement (foreign) (amended)
12:00am
6-K
EX-99.1
68lnai
16 Sep 20
Developing cannabinoid based pharmaceuticals Corporate Presentation • September 2020
7:11am
6-K
f2ta q5083amlie
20 Aug 20
Report of Foreign Private Issuer
8:31am
6-K
EX-99.3
4ta4e9p5 oltb5sum1e
1 Jul 20
Report of Foreign Private Issuer
9:05am
424B4
jcoc6w yg7bx
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
yi9mjrfn7l98a
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
EX-4.7
9v0v7cer1x
31 Mar 20
Registration statement (foreign) (amended)
11:31am